Myriad Genetics, Inc.MYGNNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank7
3Y CAGR-16.2%
5Y CAGR-13.0%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-16.2%/yr
vs -6.4%/yr prior
5Y CAGR
-13.0%/yr
Recent deceleration
Acceleration
-9.7pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
6 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$706.60M-31.2%
2024$1.03B-10.4%
2023$1.15B-4.4%
2022$1.20B-9.2%
2021$1.32B-6.9%
2020$1.42B-9.2%
2019$1.56B0.0%
2018$1.56B+33.1%
2017$1.17B-4.1%
2016$1.22B-